Abstract
Background/Objectives:
To investigate whether vitamin-B density in the diet 2–8 years before diagnosis is associated with olfactory function at the time of diagnosis.
Subjects/Methods:
This prospective nested case–control study included patients with Parkinson's disease (PD), multiple system atrophy and progressive supranuclear paralysis identified between 2004 and 2009 in the county of Västerbotten in northern Sweden. The case database (NYPUM study; Newly Diagnosed Parkinson in Umeå; n=147) was cross-linked to the Northern Sweden Health and Disease Study (NSHDS). Identified patients (n=96) and controls (n=375) were matched for sex, age, year of health survey, sub-cohort and geographical area. Dietary intake was assessed by a food frequency questionnaire, and the brief smell identification test (B-SIT) was used to measure olfactory function at the time of diagnosis.
Results:
There was no difference in vitamin-B or any other macro- or micro-nutrient densities, energy intake or body mass index (kg/m2; BMI) between patients and controls at baseline at the time of the healthcare survey. A lower thiamin and folate density, amount per 1 megajoule, was reported in patients who scored below median on B-SIT (<7) when compared with that in patients who scored ⩾7 at the time of diagnosis. After adjusting for age, sex and BMI using linear and logistic regressions, an even stronger association was found between thiamin density and olfactory function.
Conclusions:
A low thiamin and folate density in the reported diet, 2–8 years before PD diagnosis, was significantly associated with olfactory dysfunction at the time of PD diagnosis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Sharma M, Tiwari M, Tiwari RK . Hyperhomocysteinemia: Impact on Neurodegenerative Diseases. Basic Clin Pharmacol Toxicol 2015; 117: 287–296.
Klostermann F, Jugel C, Müller T, Marzinzik F . Malnutritional neuropathy under intestinal levodopa infusion. J Neural Transm 2012; 119: 369–372.
Madenci G, Bilen S, Arli B, Saka M, Ak F . Serum iron, vitamin B12 and folic acid levels in Parkinson's disease. Neurochem Res 2012; 37: 1436–1441.
Herrmann W, Obeid R . Biomarkers of folate and vitamin B (12) status in cerebrospinal fluid. Clin Chem Lab Med 2007; 45: 1614–1620.
Fukushima T . Niacin metabolism and Parkinson's disease. Environm Health Prev Med 2005; 10: 3–8.
Murakami K, Miyake Y, Sasaki S, Tanaka K, Fukushima W, Kiyohara C et al. Dietary intake of folate, vitamin B6, vitamin B12 and riboflavin and risk of Parkinson's disease: a case-control study in Japan. Br J Nutr 2010; 104: 757–764.
de Lau LM, Koudstaal PJ, Witteman JC, Hofman A, Breteler MM . Dietary folate, vitamin B12, and vitamin B6 and the risk of Parkinson disease. Neurology 2006; 67: 315–318.
Chen H, Zhang SM, Schwarzschild MA, Hernán MA, Logroscino G, Willett WC et al. Folate intake and risk of Parkinson's disease. Am J Epidemiol 2004; 160: 368–375.
Shen L . Associations between B Vitamins and Parkinson's disease. Nutrients 2015; 7: 7197–7208.
Hawkes CH, Shephard BC, Daniel SE . Is Parkinson's disease a primary olfactory disorder? QJM 1999; 92: 473–480.
Hawkes CH, Del Tredici K, Braak H . A timeline for Parkinson's disease. Parkinsonism Relat Disord 2010; 16: 79–84.
Ross GW, Petrovitch H, Abbott RD, Tanner CM, Popper J, Masaki K et al. Association of olfactory dysfunction with risk for future Parkinson's disease. Ann Neurol 2008; 63: 167–173.
Haehner A, Hummel T, Reichmann H . A clinical approach towards smell loss in Parkinson's disease. J Parkinsons Dis 2014; 4: 189–195.
Sengoku R, Matsushima S, Bono K, Sakuta K, Yamazaki M, Miyagawa S et al. Olfactory function combined with morphology distinguishes Parkinson's disease. Parkinsonism Relat Disord 2015; 21: 771–777.
Wenning GK, Shephard B, Hawkes C, Petruckevitch A, Lees A, Quinn N . Olfactory function in atypical parkinsonian syndromes. Acta Neurol Scand 1995; 91: 247–250.
Silveira-Moriyama L, Hughes G, Church A, Ayling H, Williams DR, Petrie A et al. Hyposmia in progressive supranuclear palsy. Mov Disord 2010; 25: 570–577.
Linder J, Stenlund H, Forsgren L . Incidence of Parkinson’s disease and parkinsonism in northern Sweden: a population-based study. Mov Disord 2010; 25: 341–348.
Fahn S, Elton RL the UPDRS Development Committee. Development Committee Unified Parkinson’s disease rating scale Fahn S, Marsden CD, Calne D, Goldstein M Recent Developments In Parkinson’s Disease. Macmillan Healthcare Information: Florham Park, NJ, USA, 1987; 153–164.
Gibb WR, Lees AJ . The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 1988; 51: 745–752.
Gilman S, Low PA, Quinn N, Albanese A, Ben-Shlomo Y, Fowler CJ et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999; 163: 94–98.
Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996; 47: 1–9.
Hallmans G, Agren A, Johansson G, Johansson A, Stegmayr B, Jansson JH et al. Cardiovascular disease and diabetes in the Northern Sweden Health and Disease Study Cohort - evaluation of risk factors and their interactions. Scand J Public Health Suppl 2003; 61: 18–24.
Johansson I, Hallmans G, Wikman A, Biessy C, Riboli E, Kaaks R . Validation and calibration of food-frequency questionnaire measurements in the Northern Sweden Health and Disease Cohort. Publ Health Nutr 2002; 5: 487–496.
Doty RL, Marcus A, Lee WW . Development of the 12-item Cross-Cultural Smell Identification Test (CC-SIT). Laryngoscope 1996; 106: 353–356.
van der Wielen RP, Löwik MR, Haller J, van den Berg H, Ferry M, van Staveren WA . Vitamin B-6 malnutrition among elderly Europeans: the SENECA study. J Gerontol A Biol Sci Med Sci 1996; 51: B417–B424.
Ådén E, Carlsson M, Poortvliet E, Stenlund H, Linder J, Edström M et al. Dietary intake and olfactory function in patients with newly diagnosed Parkinson's disease: a case-control study. Nutr Neurosci 2011; 14: 25–31.
Doty RL, Kamath V . The influences of age on olfaction: a review. Front Psychol 2014; 5: 20.
Haehner A, Hummel T, Reichmann H . Olfactory loss in Parkinson's disease. Parkinsons Dis 2011; 2011: 450939.
Pannunzio P, Hazell AS, Pannunzio M, Rao KV, Butterworth RF . Thiamine deficiency results in metabolic acidosis and energy failure in cerebellar granule cells: an in vitro model for the study of cell death mechanisms in Wernicke's encephalopathy. J Neurosci Res 2000; 62: 286–292.
Lonsdale D . Thiamin(e): the spark of life. Subcell Biochem 2012; 56: 199–227.
Singleton CK, Martin PR . Molecular mechanisms of thiamine utilization. Curr Mol Med 2001; 1: 197–207.
Bâ A . Metabolic and structural role of thiamine in nervous tissues. Cell Mol Neurobiol 2008; 28: 923–931.
Mulholland PJ . Susceptibility of the cerebellum to thiamine deficiency. Cerebellum 2006; 5: 55–63.
Freeman GB, Nielsen PE, Gibson GE . Effect of age on behavioral and enzymatic changes during thiamin deficiency. Neurobiol Aging 1987; 8: 429–434.
Hamada S, Hirashima H, Imaeda M, Okamoto Y, Hamaguchi-Hamada K, Kurumata-Shigeto M . Thiamine deficiency induces massive cell death in the olfactory bulbs of mice. J Neuropathol Exp Neurol 2013; 72: 1193–1202.
Tadano T, Abe Y, Morikawa Y, Asao T, Hozumi M, Takahashi N et al. Involvement of dopaminergic neurons in mouse-killing aggression in rats. Methods Find Exp Clin Pharmacol 1997; 19: 527–531.
Costantini A, Pala MI, Compagnoni L, Colangeli M . High-dose thiamine as initial treatment for Parkinson's disease. BMJ Case Rep 2013, e-pub ahead of print 28 August 2013 doi:10.1136/bcr-2013-009289.
Lu'o'ng Kv, Nguyên LT . Thiamine and Parkinson's disease. J Neurol Sci 2012; 316: 1–8.
Luong KV, Nguyên LT . The beneficial role of thiamine in Parkinson disease. CNS Neurosci Ther 2013; 19: 461–468.
Yang LK, Wong KC, Wu MY, Liao SL, Kuo CS, Huang RF . Correlations between folate, B12, homocysteine levels, and radiological markers of neuropathology in elderly post-stroke patients. J Am Coll Nutr 2007; 26: 272–278.
Singh J, Ahmad J, Kar SK . Olfactory and gustatory dysfunction in depression: Could it be a marker of folate deficiency? Aust N Z J Psychiatry 2016; 50: 99–100.
Jia H, Liu Z, Li X, Feng Z, Hao J, Li X et al. Synergistic anti-Parkinsonism activity of high doses of B vitamins in a chronic cellular model. Neurobiol Aging 2010; 31: 636–646.
Quinn MR, Chan MM . Effect of vitamin B-6 deficiency on glutamic acid decarboxylase activity in rat olfactory bulb and brain. J Nutr 1979; 109: 1694–1702.
Derin S, Koseoglu S, Sahin C, Sahan M . Effect of vitamin B12 deficiency on olfactory function. Int Forum Allergy Rhinol. e-pub ahead of print 27 April 2016 doi:10.1002/alr.21790.
Malkarnekar NA, Behere RV, Bhandary RP, Praharaj SK, Sharma PS . Olfactory perceptual abnormality associated with vitamin B12 deficiency. Psychosomatics 2014; 55: 310–311.
Mundt B, Krakowsky G, Röder H, Werner E . [Loss of smell and taste within the scope of vitamin B 12 deficiency]. Psychiatr Neurol Med Psychol (Leipz) 1987; 39: 356–361.
Acknowledgements
This work was supported by grants from The Swedish Parkinson Foundation (Svenska Parkinsonstiftelsen), Swedish Parkinson Foundation, Neuro Sweden and Västerbotten County Council (ALF).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Håglin, L., Johansson, I., Forsgren, L. et al. Intake of vitamin B before onset of Parkinson’s disease and atypical parkinsonism and olfactory function at the time of diagnosis. Eur J Clin Nutr 71, 97–102 (2017). https://doi.org/10.1038/ejcn.2016.181
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ejcn.2016.181
This article is cited by
-
Parkinson's disease and vitamins: a focus on vitamin B12
Journal of Neural Transmission (2024)
-
Homocysteine, vitamin B metabolites, dopamine-substituting compounds, and symptomatology in Parkinson’s disease: clinical and therapeutic considerations
Journal of Neural Transmission (2023)